Brain Tumors Drug Discovery Service
Creative Biolabs offers academic and industrial research services in the field of neuroscience. Based on our extensive experience and advanced platforms, now we provide one-stop research services against various brain tumors for our clients all over the world.
Introduction to Brain Tumors
Brain tumors are lumps that form when cells in the brain grow abnormally. Tumors can be benign or malignant. Benign tumors grow slowly and are less likely to spread to other parts of the body, while malignant tumors are cancerous and can spread to other areas of your brain or body. Brain tumors have a range of symptoms, depending on their location, size, and type. Surgery, radiotherapy, and chemotherapy are the most common treatments and can relieve symptoms to a great extent
Fig.1 The human brain.
Types of Brain Tumors
Brain tumors can be classified into primary and secondary types. Primary brain tumors always originate in the brain and most of them are benign. Secondary brain tumors, also known as metastatic brain tumors, come from elsewhere in the body and have spread or metastasized to the brain. There are many types of brain tumors, together with spinal cord tumors, which are collectively referred to as central nervous system (CNS) tumors.
Meningioma, also known as a meningeal tumor, is the most common type of primary brain tumor. Originating from the meninges, most meningiomas grow slowly and do not have any obvious signs and symptoms, so they do not always require immediate treatment.
Neurofibroma is a benign nerve sheath tumor arising from non-myelinating-type Schwann cells. There are two major types, including neurofibromatosis type I (NF1) and neurofibromatosis type II (NF2). The symptoms are always mild or absent.
Glioblastoma, also known as glioblastoma multiforme (GBM), is an aggressive type of brain tumor that begins within the brain. Glioblastoma forms from astrocytes that support nerve cells. Surgery, chemotherapy, and radiation therapy are currently known treatments.
Astrocytoma is a brain tumor that originates in astrocytes. As the most common type of glioma, it can occur in most parts of the brain and occasionally the spinal cord. Research suggests that astrocytoma can be a slow-growing tumor or a fast-growing aggressive cancer.
Oligodendrogliomas are gliomas that originate in oligodendrocytes, or glial precursor cells, in the brain. The cause of oligodendrogliomas is unknown and the symptoms always include seizures and headaches.
Choroid plexus tumors are primary central nervous system (CNS) tumors that occur from the choroid plexus of the brain. Depending on the size and location of the tumor, symptoms often include headache, nausea, irritability, and decreased energy. Currently, surgery and chemotherapy are the treatment of choices.
Pituitary adenomas are tumors that occur in the pituitary gland. Most adenomas are benign and the prevalence in the general population is approximately 17%.
Craniopharyngioma is a rare type of noncancerous brain tumor derived from pituitary gland embryonic tissue. The growth of a craniopharyngioma can affect the function of the pituitary gland and other nearby structures.
Schwannoma, also known as neurilemmoma, is a rare type of tumor composed of Schwann cells. Schwannomas are mostly benign, and less than 1% become malignant.
Nasopharyngeal angiofibroma, also known as juvenile nasal angiofibroma, fibromatous hamartoma, and angiofibromatous hamartoma of the nasal cavity, is an angiofibroma that arises from the superior margin of the sphenopalatine foramen. This is a benign tumor, but it is locally aggressive.
Services at Creative Biolabs
Brain Tumors Drug Discovery Service
Equipped with world-leading platforms and extensive experience, Creative Biolabs provides one-stop drug discovery service for our clients. From the basic target identification to the final IND-enabling, we can meet all the needs of customers.
Creative Biolabs is well equipped and versed in the field of neuroscience to assist our customers' research and project development. Our scientists have established advanced platforms and animal models to support one-stop therapy development with high quality and high efficiency. If you are interested in our services and products, please do not hesitate to contact us for more details.